FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1468911000001109: Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24621101000001119 Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58154201000001118 Augmentin 375mg dispersible tablets (GlaxoSmithKline UK Ltd) 21 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Is a Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Is pack of Augmentin 375mg dispersible tablets (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has AMP Augmentin 375mg dispersible tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start